Financials

Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.71
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1782
ATAI
AtaiBeckley Inc. - Common Stock
7.42 USD+0.95%+0.27%+3.63%+87.85%2.75 B USD
1812
NRIX
Nurix Therapeutics, Inc. - Common stock
25.43 USD-1.51%-6.47%+7.30%+126.85%2.64 B USD
1824
BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
10.03 USD-1.38%+3.40%+13.72%+21.28%2.56 B USD
1828
VERA
Vera Therapeutics, Inc. - Class A Common Stock
35.48 USD-0.50%+3.50%+8.50%+19.30%2.56 B USD

Noticias